Pharmacological treatment of diabetes in older people
Open accessAbstract
The pharmacological management of diabetes in older people is complex and challenging. It requires a comprehensive understanding of the individual beyond the diabetes itself. Through the ageing years, the older individual presents with diabetes-related and non-related comorbidities and complications, develops functional limitations and psychological issues, and may lack social support and access to care. A disturbance in these categories, known as the four geriatric domains, will negatively affect diabetes self-management and self-efficacy, leading to poor outcomes and complications. Furthermore, older people with diabetes may be more interested in the management of other chronic conditions such as pain or impaired mobility, and diabetes may be lower in their list of priorities. Proper education must be provided to the older individual and caregivers, with continuous monitoring and counselling, especially when pharmacological interventions offer risks of side effects, adverse reactions and interactions with other medications. Informed shared medical decisions will help to improve adherence to the regimen; however, such discussions ought to be based on the best evidence available, which is unfortunately limited in this age group. We performed a review focused on pharmacological agents and summarize current evidence on their use for the treatment of diabetes in older people. We encourage clinicians to investigate and incorporate the four geriatrics domains in the selection and…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Older adults with diabetes may have cognitive impairment and functional impairment.
“Special care is required in prescribing and monitoring pharmacologic therapies in older adults (96), who are at high risk of polypharmacy, have difficulties in maintaining prescribed medication plans, and may have cognitive impairment and functional impairment.”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [96]
Older adults with diabetes are at high risk of polypharmacy.
“Special care is required in prescribing and monitoring pharmacologic therapies in older adults (96), who are at high risk of polypharmacy, have difficulties in maintaining prescribed medication plans, and may have cognitive impairment and functional impairment.”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [96]
Special care is required in prescribing and monitoring pharmacologic therapies in older adults.
“Special care is required in prescribing and monitoring pharmacologic therapies in older adults (96),”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [96]
Older adults with diabetes have difficulties maintaining prescribed medication plans.
“Special care is required in prescribing and monitoring pharmacologic therapies in older adults (96), who are at high risk of polypharmacy, have difficulties in maintaining prescribed medication plans, and may have cognitive impairment and functional impairment.”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [96]
Cites
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572 · see citing works
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919 · see citing works
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578 · see citing works
Acarbose in the treatment of elderly patients with type 2 diabetes
Josse, R. G., Chiasson, J.-L., Ryan, E. A., Lau, D. C. W., Ross, S. A., Yale, J.-F., Leiter, L. A., Maheux, P., Tessier, D., Wolever, T. M. S., et al. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00176-6 · Cited by 110 · see citing works
Classification of Older Adults Who Have Diabetes by Comorbid Conditions, United States, 2005–2006
Laiteerapong, N., Iveniuk, J., John, P., Laumann, E., & Huang, E. (2012) · Preventing Chronic Disease · doi:10.5888/pcd9.110287 · Cited by 44 · see citing works
Pawaskar, M., Li, Q., & Reynolds, M. W. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.686901 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
13. Older Adults: <i>Standards of Medical Care in Diabetes—2022</i>
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s013 · Cited by 381 · see citing works
13. Older Adults: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s013 · Cited by 209 · see citing works
13. Older Adults: <i>Standards of Care in Diabetes—2024</i>
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s013 · Cited by 161 · see citing works
Metformin and ageing: improving ageing outcomes beyond glycaemic control
Valencia, W. M., Palacio, A., Tamariz, L., & Florez, H. (2017) · Diabetologia · doi:10.1007/s00125-017-4349-5 · Cited by 142 · see citing works
Self-citation
- Authors
- Valencia, W. M., & Florez, H.
- Affiliations
- University of Miami (US)
- Corresponding author
- Valencia, W. M.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2014-09-11
- Volume
- 16
- Issue
- 12
- Pages
- 1192-1203
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2047362353
- Cited by
- 62
- References
- 6
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 5 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 5
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Obesity and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- pharmacotherapy, antidiabetic drugs, comorbidities, functional limitations, diabetes self-management, self-efficacy, adverse drug reactions, drug interactions, shared decision-making, medication adherence, patient education
- MeSH terms
- Activities of Daily Living, Age Factors, Aged, Aged, 80 and over, Aging, Diabetes Mellitus, Drug Interactions, Health Services Accessibility, Humans, Hypoglycemic Agents, Patient Education as Topic, Quality of Life, Risk Factors, Self Care, Social Support, Comorbidity, Disease Progression, Polypharmacy, Diabetes Complications, Medication Adherence, Health Literacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review